Dawn of light: opportunities and challenges in small cell lung cancer immunotherapy
10.3760/cma.j.cn101721-20211210-000259
- VernacularTitle:小细胞肺癌免疫治疗的机遇与挑战
- Author:
Guogui SUN
1
;
Weinan YAO
Author Information
1. 华北理工大学附属医院肿瘤科，唐山 063000
- Keywords:
Small cell lung cancer;
Immunotherapy;
Molecular subtyping;
Tumor biomark
- From:
Clinical Medicine of China
2022;38(1):1-4
- CountryChina
- Language:Chinese
-
Abstract:
Small cell lung cancer accounts for about 15% of all lung cancers, and is a highly invasive neuroendocrine tumor. smoking is a major risk factor. SCLC grows rapidly, has a high metastasis rate and has a poor prognosis. For more than 30 years, the treatment of SCLC has progressed slowly, until the emergence of immunodrugs in recent years, which have achieved certain efficacy in a wide range of patients.
